VCAM1 Expression in Glioma Models and Patient Survival Data

Data Sheet 2_Glia-derived VCAM1 promotes glioma progression.csv contains data from a study investigating VCAM1's role in glioma progression. The dataset likely includes expression correlations and survival outcomes from human glioma datasets and mouse models. The data was authored by Jiajing Dai and uploaded to figshare on April 24, 2026.

Use Cases

• Correlating VCAM1 expression levels with patient survival outcomes based on clinical data mentioned in the description
• Analyzing co-expression patterns of VCAM1 with markers like SOX2, CD133, and Ki67 based on findings from mouse models
• Comparing VCAM1 expression in tumor versus stromal cell populations based on characterization from syngeneic models
• Evaluating the impact of genetic background and tumor location on therapeutic efficacy based on survival differences observed in mouse models

Strengths

• Includes specific co-expression percentages, such as 86.5% of SOX2+ cells co-expressing VCAM1
• Contains survival data with concrete median survival times, such as from 52 to 66.5 days in a mouse model
• Correlates findings with clinical data on patient survival outcomes

Limitations

• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment
• Data may reflect temporal or source bias inherent to the specific research study

Provenance

Source

figshare

Collection Method

Likely contains experimental results from mouse glioma models and analysis of human glioma datasets.

Freshness

Last updated 2026-04-24 04:23:04; freshness should be verified